Back to Search Start Over

Drug prevents ADT-related bone loss

Authors :
Schieszer, John
Source :
Renal & Urology News. Nov-Dec, 2005, Vol. 4 Issue 10, p1, 2 p.
Publication Year :
2005

Abstract

NASHVILLE -- Using alendronate (Fosamax) once weekly appears to be safe and effective for preventing bone loss in men on androgen deprivation therapy (ADT) for prostate cancer, according to data [...]

Subjects

Subjects :
Prostate cancer -- Drug therapy -- Prevention -- Research -- Health aspects
Alendronate -- Health aspects -- Research
Bone diseases -- Prevention -- Research -- Drug therapy -- Health aspects
Health
University of Pittsburgh -- Research

Details

Language :
English
ISSN :
15509478
Volume :
4
Issue :
10
Database :
Gale General OneFile
Journal :
Renal & Urology News
Publication Type :
Periodical
Accession number :
edsgcl.140523449

Tools

Authors Abstract Subjects Details